LC-MS-based serum metabolomics analysis for the screening and monitoring of colorectal cancer
- PMID: 37448516
- PMCID: PMC10338013
- DOI: 10.3389/fonc.2023.1173424
LC-MS-based serum metabolomics analysis for the screening and monitoring of colorectal cancer
Abstract
Background: Colorectal Cancer (CRC) is a prevalent digestive system tumour with significant mortality and recurrence rates. Serum metabolomics, with its high sensitivity and high throughput, has shown potential as a tool to discover biomarkers for clinical screening and monitoring of the CRC patients.
Methods: Serum metabolites of 61 sex and age-matched healthy controls and 62 CRC patients (before and after surgical intervention) were analyzed using a ultra-performance liquid chromatography-high resolution mass spectrometer (UPLC-MS). Statistical methods and pathway enrichment analysis were used to identify potential biomarkers and altered metabolic pathways.
Results: Our analysis revealed a clear distinction in the serum metabolic profile between CRC patients and healthy controls (HCs). Pathway analysis indicated a significant association with arginine biosynthesis, pyrimidine metabolism, pantothenate, and CoA biosynthesis. Univariate and multivariate statistical analysis showed that 9 metabolites had significant diagnostic value for CRC, among them, Guanosine with Area Under the Curve (AUC) values of 0.951 for the training group and0.998 for the validation group. Furthermore, analysis of four specific metabolites (N-Phenylacetylasparticacid, Tyrosyl-Gamma-glutamate, Tyr-Ser and Sphingosine) in serum samples of CRC patients before and after surgery indicated a return to healthy levels after an intervention.
Conclusion: Our results suggest that serum metabolomics may be a valuable tool for the screening and monitoring of CRC patients.
Keywords: biomarkers; colorectal cancer; liquid chromatography-mass spectrometer; monitoring; screening; serum metabolomics.
Copyright © 2023 Yi, Wang, Liang, Ren, Lian, Han and Sun.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.Dis Markers. 2021 Dec 7;2021:6858809. doi: 10.1155/2021/6858809. eCollection 2021. Dis Markers. 2021. PMID: 34917201 Free PMC article. Clinical Trial.
-
Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.BMC Med. 2010 Feb 15;8:13. doi: 10.1186/1741-7015-8-13. BMC Med. 2010. PMID: 20156336 Free PMC article.
-
Specificity of metabolic colorectal cancer biomarkers in serum through effect size.Metabolomics. 2020 Aug 13;16(8):88. doi: 10.1007/s11306-020-01707-w. Metabolomics. 2020. PMID: 32789702
-
Global serum metabolomics profiling of colorectal cancer.Mol Clin Oncol. 2019 Jul;11(1):3-14. doi: 10.3892/mco.2019.1853. Epub 2019 May 8. Mol Clin Oncol. 2019. PMID: 31289671 Free PMC article. Review.
-
The Application of Metabolomics in Recent Colorectal Cancer Studies: A State-of-the-Art Review.Cancers (Basel). 2022 Jan 30;14(3):725. doi: 10.3390/cancers14030725. Cancers (Basel). 2022. PMID: 35158992 Free PMC article. Review.
Cited by
-
Age-associated decline of Coenzyme A leads to intestinal stem cells dysfunction via disturbing iron homeostasis.PLoS Genet. 2025 May 30;21(6):e1011704. doi: 10.1371/journal.pgen.1011704. eCollection 2025 Jun. PLoS Genet. 2025. PMID: 40446021 Free PMC article.
-
Predictive modeling of colorectal cancer using exhaustive analysis of microbiome information layers available from public metagenomic data.Front Microbiol. 2024 Aug 26;15:1426407. doi: 10.3389/fmicb.2024.1426407. eCollection 2024. Front Microbiol. 2024. PMID: 39252839 Free PMC article.
-
Causality of metabolites and metabolic pathways on cholestatic liver diseases: a Mendelian randomization study.Front Med (Lausanne). 2024 Jul 2;11:1395526. doi: 10.3389/fmed.2024.1395526. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39015781 Free PMC article.
-
Association analysis of gut microbiota with LDL-C metabolism and microbial pathogenicity in colorectal cancer patients.Lipids Health Dis. 2024 Nov 8;23(1):367. doi: 10.1186/s12944-024-02333-4. Lipids Health Dis. 2024. PMID: 39516755 Free PMC article.
-
Mitochondrial medicine: "from bench to bedside" 3PM-guided concept.EPMA J. 2025 Apr 15;16(2):239-264. doi: 10.1007/s13167-025-00409-4. eCollection 2025 Jun. EPMA J. 2025. PMID: 40438494 Free PMC article.
References
-
- Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, et al. . Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res (2009) 8(1):352–61. doi: 10.1021/pr8006232 - DOI - PubMed
LinkOut - more resources
Full Text Sources